LEXINGTON, MA & EXTON, PA, USA I October 24, 2011 I -Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced that they have signed a definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash, or approximately $190 million on a fully-diluted basis, net of Adolor's third quarter 2011 cash balance.
Cubist Pharmaceuticals to acquire Adolor